sir
viral
diseas
one
lead
caus
morbid
mortal
world
novel
coronaviru
design
recent
emerg
wuhan
china
end
march
thousand
report
case
greater
death
wordwid
given
race
time
identifi
drug
treatment
option
soon
possibl
critic
adequ
respond
outbreak
one
drug
multipl
virus
paradigm
came
discoveri
broadspectrum
antivir
agent
bsaa
smallmolecul
inhibit
wide
rang
human
virus
even
pertin
today
outbreak
ebola
zika
dengu
influenza
viral
infect
especi
sinc
ident
sarscov
even
close
relat
sever
bat
coronavirus
molecul
lopinavirritonavir
nucleosid
analogu
neuraminidas
inhibitor
remdesivir
fusion
peptid
abidol
rna
synthesi
inhibitor
tdf
ifnalpha
chines
tradit
medicin
shufengjiedu
capsul
lianhuaqingwen
capsul
potenti
treatment
option
emerg
viru
howev
efficaci
safeti
drug
requir
confirm
clinic
experi
chronic
kidney
diseas
ckd
frequent
encount
gener
popul
risk
increas
viral
morbid
approxim
us
adult
million
peopl
estim
ckd
http
first
month
current
outbreak
china
ckd
report
chines
infectedpati
sever
present
endstag
kidney
diseas
patient
highli
suscept
group
infect
rate
exce
observ
popul
http
context
epidem
pandem
drug
prescrib
ckd
andor
eskd
patient
clinician
thu
awar
potenti
dosag
adjust
renal
advers
event
drug
patient
group
tabl
phase
iv
avail
aki
fatal
acut
hepatoren
failur
